Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Establishment and evaluation of a novel biomarker-based nomogram for malignant phaeochromocytomas and paragangliomas.

Clinical endocrinology - 1 Aug 2017

Zhong Xu, Ye Lei, Su TingWei, Xie Jing, Zhou Weiwei, Jiang Yiran, Jiang Lei, Ning Guang, Wang Weiqing

Abstract excerpt

OBJECTIVE: No single histological or molecular marker is diagnostic for malignant phaeochromocytomas and paragangliomas (PPGLs). This study aimed to establish and evaluate a prognostic nomogram to improve the prediction of metastatic probability in individual PPGL patients. METHODS: Three hundred and 47 consecutive PPGL patients from January 2002 through December 2014 were randomly divided into a training set...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Gland Neoplasms
Share to Area Under Curve

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nomograms

Share to Paraganglioma

Share to Pheochromocytoma

Share to Receptor, ErbB-2

Share to ROC Curve

Share to Succinate Dehydrogenase

Source

Identifiers

PMID: 28429830
DOI: 10.1111/cen.13357

Genes

SDHB

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Establishment and evaluation of a novel biomarker-based nomogram for malignant phaeochromocytomas and paragangliomas.PMID 28429830Read ↗

Predictors of outcome in phaeochromocytomas and paragangliomasSemantic proximity Read ↗

Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task ForceSemantic proximity Read ↗

Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical MedicineSemantic proximity Read ↗

Genetic and Molecular Biomarkers in Aggressive Pheochromocytomas and Paragangliomas.Semantic proximity Read ↗

Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical MedicineSemantic proximity Read ↗

Metastatic pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Joint application of multiple genes in the diagnosis and pathogenesis of metastatic peochormocytoma/paraganglioma based on bioinformaticsSemantic proximity Read ↗

Metastatic Pheochromocytoma and Paraganglioma: Clinicopathological Analysis of 35 CasesSemantic proximity Read ↗

Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual PatientsSemantic proximity Read ↗

Malignant pheochromocytoma.Semantic proximity Read ↗

The Molecular Classification of Pheochromocytomas and Paragangliomas: Discovering the Genomic and Immune Landscape of Metastatic DiseaseSemantic proximity Read ↗

A Guide to Pheochromocytomas and Paragangliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.